Identifying patients with non-valvular atrial fibrillation & poorly controlled INR on warfarin who are suitable to be switched to NOACs

被引：0
|
作者：
Ahmad, H. N. [1 ]
Van Staden, B. [1 ]
Haque, A. [1 ]
Khan, A. [1 ]
Gul, A. [1 ]
机构：
[1] Burton Hosp NHS Fdn Trust, Dept Haematol, Burton Upon Trent, Staffs, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2014年 / 165卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
92
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [41] Uninterrupted dabigatran versus warfarin in the treatment of intracardiac thrombus in patients with non-valvular atrial fibrillation
    Hao, Li
    Zhong, Jing-quan
    Zhang, Wei
    Rong, Bing
    Xie, Fei
    Wang, Jun-tao
    Yue, Xin
    Zheng, Zhao-tong
    Zhu, Qing
    Zhang, Yun
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 190 : 63 - 66
  • [42] Psychiatric symptoms in patients with non-valvular atrial fibrillation
    Manar Yossef
    Reham Amer
    Hatem Elsokkary
    Gamal Shama
    [J]. Middle East Current Psychiatry, 29
  • [43] Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Coleman, Craig I.
    Thomson, Erin
    Smith, David M.
    Damaraju, C. V.
    Schein, Jeffrey R.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (12) : 2461 - 2469
  • [44] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Faye L. Norby
    Lindsay G.S. Bengtson
    Pamela L. Lutsey
    Lin Y. Chen
    Richard F. MacLehose
    Alanna M. Chamberlain
    Ian Rapson
    Alvaro Alonso
    [J]. BMC Cardiovascular Disorders, 17
  • [45] Healthcare Utilization (HCRU) Among Non-Valvular Atrial Fibrillation (NVAF) Patients Who Switched From Warfarin to an Novel Oral Anti-Coagulant (NOAC)
    Franchino-Elder, Jessica
    Gilligan, Adrienne
    Song Xue
    Wang Cheng
    Henriques, Caroline
    Nguyen, Amy
    [J]. STROKE, 2019, 50
  • [46] Effect and risk of novel oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Kawada, Tomoyuki
    [J]. JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 99
  • [47] Uninterrupted Dabigatran versus Warfarin in the Treatment of Intracardiac Thrombus in Patients with non-Valvular Atrial Fibrillation
    Hao, Li
    Zhong, Jingquan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C229 - C229
  • [48] Stroke and bleeding with NOAC and warfarin in patients with non-valvular atrial fibrillation in the Stockholm healthcare system
    Forslund, T.
    Wettermark, B.
    Hjemdahl, P.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 792 - 792
  • [49] Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes
    Hernandez, Adrian, V
    Bradley, George
    Khan, Mohammad
    Fratoni, Andrew
    Gasparini, Anna
    Roman, Yuani M.
    Bunz, Thomas J.
    Eriksson, Daniel
    Meinecke, Anna-Katharina
    Coleman, Craig, I
    [J]. EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2020, 6 (04) : 301 - 307
  • [50] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Norby, Faye L.
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Chamberlain, Alanna M.
    Rapson, Ian
    Alonso, Alvaro
    [J]. BMC CARDIOVASCULAR DISORDERS, 2017, 17
12345